KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Inventory (2016 - 2025)

Historic Inventory for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to $27.8 million.

  • Biolife Solutions' Inventory fell 1353.06% to $27.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.8 million, marking a year-over-year decrease of 1353.06%. This contributed to the annual value of $29.0 million for FY2024, which is 680.68% up from last year.
  • Per Biolife Solutions' latest filing, its Inventory stood at $27.8 million for Q3 2025, which was down 1353.06% from $27.7 million recorded in Q2 2025.
  • Over the past 5 years, Biolife Solutions' Inventory peaked at $43.4 million during Q1 2024, and registered a low of $11.7 million during Q1 2021.
  • For the 5-year period, Biolife Solutions' Inventory averaged around $31.5 million, with its median value being $30.2 million (2022).
  • Its Inventory has fluctuated over the past 5 years, first soared by 16905.86% in 2021, then plummeted by 3650.44% in 2025.
  • Over the past 5 years, Biolife Solutions' Inventory (Quarter) stood at $28.3 million in 2021, then increased by 23.14% to $34.9 million in 2022, then decreased by 22.18% to $27.2 million in 2023, then grew by 6.81% to $29.0 million in 2024, then fell by 4.09% to $27.8 million in 2025.
  • Its Inventory was $27.8 million in Q3 2025, compared to $27.7 million in Q2 2025 and $27.6 million in Q1 2025.